after a nice pop on the abviy physical euro, bristol myers has been -- failure, bristol myers has beenown almost 9% from its highs. i cannot give a good reason. the pullback simply reflects concerns about the group, has nothing to do bristol myers specifically. even if the rally is some 42% from early july lows, this stock sells for 7.9 times. and that's the cheapest pharmaceutical company in the s&p 500. aside from the unpopular moderna. bristol myers sports a 4.4% yield. the second best in the group. the fundamentals improved directly in the second half of the year. the stock is dirt cheap. you're getting paid to wait for the juicy dividend. here's the bottom line, with so many groups hitting new highs, i think it's worth taking a step back and putting money to work in one of the most hated groups, health care. stocks have gotten too cheap given prospects, eli lilly, bristol myers. stick around for the rest of the week. i'll give you new fresh health care ideas at cheap prices. let's go to ron in new york. ron? >> caller: hello, jim. six-time caller. >> wow. >> caller: i'm interested